Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  United Therapeutics Corporation    UTHR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. engages in the development and commercialization of innovative products for patients with chronic and life-threatening diseases.

It markets and sells commercial therapies to treat pulmonary arterial hypertension, high-risk neuroblastoma.

It is also involved in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies.

The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 750 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,466100%1,599100% +9.08%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States1,35392.3%1,46291.4% +8.05%
Rest of World112.767.7%136.908.6% +21.41%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA621996Chairman & Chief Executive Officer
Michael Benkowitz452011President & Chief Operating Officer
James Christopher Edgemond492013CFO, Treasurer & Principal Accounting Officer
Raymond C. Kurzweil, PhD692002Independent Director
Louis Wade Sullivan, MD832013Independent Director
Raymond Allen Dwek752002Non-Independent Director
Christopher Patusky532002Vice Chairman
Christopher Causey, MBA542003Independent Director
Richard Giltner532009Independent Director
Tommy George Thompson752010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 69,774,946 42,710,724 61.2% 26,332,052 37.7% 61.2%
Shareholders
NameEquities%
Fidelity Management & Research Co. 4,248,441 9.78%
BlackRock Fund Advisors 4,179,998 9.62%
The Vanguard Group, Inc. 3,810,146 8.77%
AQR Capital Management LLC 2,189,201 5.04%
SSgA Funds Management, Inc. 2,014,506 4.64%
Palo Alto Investors LLC 1,867,315 4.30%
Goldman Sachs & Co. LLC (Private Banking) 1,415,095 3.26%
Acadian Asset Management LLC 1,094,946 2.52%
Schroder Investment Management Ltd. 1,023,992 2.36%
Renaissance Technologies LLC 837,600 1.93%
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
UNITED THERAPEUTICS CORPORATION-16.25%5 257
INCYTE CORPORATION13.96%24 054
QUINTILES IMS HOLDINGS INC33.89%22 162
LONZA GROUP59.15%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.208.84%10 522
SEATTLE GENETICS, INC.21.30%9 134
IONIS PHARMACEUTICALS INC33.58%8 007
QIAGEN NV17.88%7 878
ALKERMES PLC-8.08%7 772
ICON PLC52.07%6 141
EXACT SCIENCES CORPORATION248.95%5 854
INC RESEARCH HOLDINGS INC5.61%5 782
CHARLES RIVER LABORATORIES INTL. INC50.54%5 481
PRA HEALTH SCIENCES INC49.49%5 193
GALAPAGOS41.02%5 159
BIO-TECHNE CORP19.74%4 646
PUMA BIOTECHNOLOGY INC296.09%4 638
ACADIA PHARMACEUTICALS INC.24.24%4 446
FIBROGEN INC157.24%4 316
NEKTAR THERAPEUTICS98.13%3 777
Connections : United Therapeutics Corpor
State Bar of Wisconsin
Vital Decisions LLC
X PRIZE Foundation
Singularity Education Group
Causey Consortium
The Sullivan Alliance
FatKat, Inc.
Morehouse School of Medicine
Cleveland HeartLab, Inc.
Public Broadcasting Atlanta
Lung Biotechnology PBC
America's Public Television Stations
Thompson Holdings, Inc.
Synthetic Genomics, Inc.
Kurzweil Technologies, Inc.
Medical Learning Co., Inc.
Accordia Global Health Foundation
Oxford Glycobiology Institute
Armada Media Corp.
University of Oxford
Medical Missions For Children, Inc.
Slater Run Vineyards LLC
The District of Columbia Bar
Patusky Associates LLC
MTS Health Investors LLC
© 2017 People , Fundamentals and Ownership